| 摘要 |
The purpose of the present invention is to provide a method for predicting patients for whom there will be a high likelihood of efficacy of sequential therapy involving interferon therapy subsequent to therapy with nucleic acid analogues. The problem can be overcome by this method for predicting interferon therapeutic efficacy, which is characterized by comprising: (1) a step for measuring IFN-λ3 concentration and HBs antigen concentration in an analyte derived from an HBV-infected patient; and (2) a step for comparing the measured IFN-λ3 concentration and HBs antigen concentration to respectively predetermined cutoff values, and, in the event that the IFN-λ3 concentration is no less than, or is greater than, the cutoff value, and the HBs antigen concentration is no greater than, or is less than, the cutoff value, predicting that interferon therapy is highly likely to be effective. |
